Personalised to support your treatment decisions
EAN 2020 recently brought together thousands of neurologists for four days of virtual sessions, ePosters and plenaries. If you couldn’t make it, catch-up on what you missed with our summary of the highlights from this year’s virtual EAN congress.
A multinational registry analysis in the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19 was carried out, with results published in The Lancet. According to the paper: “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”, the registry comprised data from 671 hospitals in six continents.